After more than 10 years of searching, researchers have identified a compound produced by the senior workers in a hon...
Business Editors/Health & Medical WritersBALTIMORE--(BW HealthWire)--May 6, 2002Clinical Trial Results Presented a...
Business EditorsMEMPHIS, Tenn.--(BUSINESS WIRE)--Nov. 3, 2003Accredo Health, Incorporated (NASDAQ: ACDO) today reporte...
Clozapine is an antipsychotic medication. It works by changing the actions of chemicals in the brain. Clozapine is used...
Tokyo, Japan, Sept 13, 2005 - (JCNN) - Aventis Pharma, Ajinomoto and Eisai jointly announced on September 12 that the...
Men with advanced cases of prostate cancer now have an additional treatment option. In November 2003, the FDA approved Plenaxis (abarelix), a drug given as an injection. Plenaxis lowers the male hormone testosterone, a key factor involved in most prostate cancer growth.